An interventional study of Stimulance in Intestinal Pseudo-Obstruction, Short Bowel Syndrome and Malabsorption Syndrome Autoimmune Enteropathy, sponsored by Oslo University Hospital. Completed at 1 site in Norway. Open to participants aged 1 Year to 18 Years. Per ClinicalTrials.gov, last updated 2024-06-21.
Sponsored by Oslo University Hospital · Not applicable, Interventional, and Treatment
Children with intestinal failure have a lack of tolerance for food in the intestine. The children are dependent on intravenous nutrition over a long period of time period to ensure growth and development. The condition is characterized by bacterial overgrowth in the intestine, with nausea, vomiting, diarrhea and flatulence as physical symptoms. Mental health is affected in the form of lower quality of life, lack of school participation and less social contact with peers. The investigators own (unpublished) data show that children with intestinal failure have a lower quality of life than healthy people. Standard treatment is antibiotics, but the effect of these is short-lived, and many must have repeated courses. Prebiotics are indigestible carbohydrates (fiber) in foods that positively affect the bacterial flora and promote intestinal health. In this project the investigators want to see if supply of prebiotics can change the bacterial balance, reduce symptoms of bacterial overgrowth and increase quality of life. The study is unique, as Prebiotics have not previously been used in the treatment of intestinal failure. If successful, it can pave the way for a new and better treatment method that can potentially be transferred to other conditions with imbalance in the intestinal flora. The study is a randomized intervention study and is consist of two phases. In phase 1, the effect of 4 weeks of open intervention with prebiotics is studied to establish so-called "proof of concept". Data from phase 1 are used to look at connections between the composition of intestinal flora, nutritional status and bowel function. The intervention involves the use of a prebiotic product (Stimulance, Nutricia), which is added to childs regular food. In phase 2, patients are randomized into two groups. One group will continue with the product for 6 months, while the other group does not receive prebiotics.
Quality of life, gastrointestinal symptoms and family impact are measured using validated forms for four weeks before intervention phase 1, at start-up and after phase 1, as well as after phase 2. Stool samples are collected at the same time points. Weight, height is measured and blood tests are collected at the start and end of phases 1 and 2. Data on diet and nutritional treatment are collected at the start and end of the two phases. The stool samples are analyzed for short fatty acids (marker for good intestinal health), the composition of the intestinal flora and inflammation markers. Blood samples are analyzed for infection markers, intestinal health markers and nutritional markers. Nutritional data are analyzed for nutrient content and the dependence on nutritional support is calculated.
The investigators expect that the study will lead to an improved quality of life for the patient group through increased tolerance to food in the intestine, reduced antibiotic use and reduction of gastrointestinal symptoms. The project is patient-oriented.
26 studies on the registry are indexed under Intestinal Pseudo-Obstruction; 6 are open to participants now.
This study's enrollment of 56 is close to the median of 60 across 18 interventional studies indexed under Intestinal Pseudo-Obstruction.
Browse Intestinal Pseudo-Obstruction studies →Oslo University Hospital is the lead sponsor of 834 studies on the registry; 149 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
And Treated with parenteral nutrition for minimum 60 days within a 74 day period.
Exclusion criteria:
4 weeks intervention with Stimulance for all participants
Dietary Supplement: Stimulance
6 months intervention
Dietary Supplement: Stimulance
6 months control group
Intervention with Prebiotic supplement
Changes in Quality of life scores before and after treatment with prebiotics
Changes in Pediatric quality of life inventory scores on an analog scale from 0-100 where higher scores means better outcome
Time frame: 6 months
Changes in gastro intestinal symptoms scores before and after treatment with prebiotics
Pediatric quality of life inventory Gastro intestinal symptom scale scores on an analog scale from 0-100 where higher scores means better outcome
Time frame: 6 months
Changes in familt impact scores before and after treatment with prebiotics
Pediatric quality of life inventory Family Impact Module scores on an analog scale from 0-100 where higher scores means better outcome
Time frame: 6 months
Changes in Microbiota
Measured by Short Chain Fatty Acids and microbiota composition
Time frame: 6 months
Plan to share: No
Ran from Sep 2021 to primary completion in Dec 2023, 27 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jun 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Intestinal Pseudo-Obstruction →